This site is intended for health professionals only

Friday 18 October 2019

Carlo Selmi MD PhD

Articles by this author

Thu 18 July
Thu 18 July
The development of high-throughput ‘omics’ technologies (genomics, transcriptomics or metabolomics) that allow simultaneous examination of thousands of genes, transcripts and proteins is expected to change the playing field
Mon 3 June
Mon 3 June
The management and treatment of rheumatoid arthritis is becoming more individualised thanks to the combined efforts of basic scientists and clinicians
Tue 26 March
Tue 26 March
In contrast to rheumatoid arthritis, no serum autoantibody is associated with psoriatic arthritis, whereas other biomarkers have been proposed for early diagnosis of the disease or to predict treatment response for a more adequate allocation of resources
Mon 11 February
Mon 11 February
Current genotyping capacity and proteomic tools strongly support the likelihood of the success of a personalised medicine approach in rheumatology and autoimmunity
Mon 1 October
Mon 1 October
The ability to understand and manage psoriatic arthritis has progressed enormously over the past few years and we are thus approaching a more personalised approach